Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Heinrich

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
MMW Fortschritte Der Medizin|December 15, 2020
["Curing formerly incurable diseases" - Advances in cancer-treatment]Kathrin Heinrich
BMJ Oncology|January 31, 2025
Inclusive oncological trials and targeted treatments cannot ignore sex and genderKathrin Heinrich, Sabine Oertelt-Prigione
Journal of Cancer Research and Clinical Oncology|January 13, 2023
Quo vadis precision oncology?Kathrin Heinrich, C Benedikt Westphalen
Journal of Cancer Research and Clinical Oncology|November 12, 2024
Oncological junior groups across medical specialties in Germany join forces and launch an interdisciplinary alliance: Young Oncologists United (YOU)Adrien Holzgreve, Kathrin Heinrich, Matthias Mäurer, et al.
Oncology Research and Treatment|December 18, 2024
The Critical Role of Sex and Gender in MedicineKathrin Heinrich, Marie von Lilienfeld-Toal
Deutsche Medizinische Wochenschrift (1946)|August 27, 2021
[Management of toxicities from immunotherapy]Kathrin Heinrich, Michael von Bergwelt-Baildon, Sebastian Theurich
International Journal of Environmental Research and Public Health|January 21, 2023
An Iterative, Participatory Approach to Developing a Neighborhood-Level Indicator System of Health and WellbeingHannah Röhrbein, Jennifer Hilger-Kolb, Kathrin Heinrich, et al.
Current Pharmaceutical Design|March 4, 2010
High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular diseaseChristian Besler, Kathrin Heinrich, Meliana Riwanto, et al.
MMW Fortschritte Der Medizin|April 6, 2024
[Personalized diagnostics for GI tumors: Which is useful?]Christian Heiliger, Kathrin Heinrich, Stefan Holdenrieder, et al.
Macromolecular Bioscience|September 23, 2016
Passive Tumor Targeting of Polymer Therapeutics: In Vivo Imaging of Both the Polymer Carrier and the Enzymatically Cleavable Drug ModelRobert Pola, Anne-Kathrin Heinrich, Thomas Mueller, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
MMW Fortschritte Der Medizin|December 15, 2020
["Curing formerly incurable diseases" - Advances in cancer-treatment]Kathrin Heinrich
BMJ Oncology|January 31, 2025
Inclusive oncological trials and targeted treatments cannot ignore sex and genderKathrin Heinrich, Sabine Oertelt-Prigione
Journal of Cancer Research and Clinical Oncology|January 13, 2023
Quo vadis precision oncology?Kathrin Heinrich, C Benedikt Westphalen
Journal of Cancer Research and Clinical Oncology|November 12, 2024
Oncological junior groups across medical specialties in Germany join forces and launch an interdisciplinary alliance: Young Oncologists United (YOU)Adrien Holzgreve, Kathrin Heinrich, Matthias Mäurer, et al.
Oncology Research and Treatment|December 18, 2024
The Critical Role of Sex and Gender in MedicineKathrin Heinrich, Marie von Lilienfeld-Toal
Deutsche Medizinische Wochenschrift (1946)|August 27, 2021
[Management of toxicities from immunotherapy]Kathrin Heinrich, Michael von Bergwelt-Baildon, Sebastian Theurich
International Journal of Environmental Research and Public Health|January 21, 2023
An Iterative, Participatory Approach to Developing a Neighborhood-Level Indicator System of Health and WellbeingHannah Röhrbein, Jennifer Hilger-Kolb, Kathrin Heinrich, et al.
Current Pharmaceutical Design|March 4, 2010
High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular diseaseChristian Besler, Kathrin Heinrich, Meliana Riwanto, et al.
MMW Fortschritte Der Medizin|April 6, 2024
[Personalized diagnostics for GI tumors: Which is useful?]Christian Heiliger, Kathrin Heinrich, Stefan Holdenrieder, et al.
Macromolecular Bioscience|September 23, 2016
Passive Tumor Targeting of Polymer Therapeutics: In Vivo Imaging of Both the Polymer Carrier and the Enzymatically Cleavable Drug ModelRobert Pola, Anne-Kathrin Heinrich, Thomas Mueller, et al.
Pageof 7